Arca
Skip to content
Tools
Tools

Inplex CF Molecular Test

System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection. 510(k) K063787, from Third Wave Technologies, Inc. (Madison, WI). Product code NUA, class 2.

As of Nov 20, 2026, K063787 is an FDA 510(k) held by Third Wave Technologies, Inc., substantially equivalent on Mar 13, 2008 after 448 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 448 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

InPlexâ„¢ CF Molecular Test is an in vitro diagnostic device used to simultaneously detect and identify a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA samples isolated from human peripheral whole blood specimens.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • K043011K043011

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K063787, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Mar 31, 2016Z-1580-2016Complaints of false positive HET mutations and leaking cards; could lead to unnecessary invasive testing during pregnancy and the associated risks of such invasive testing.Terminated

Record

Type
Traditional
Received
Dec 21, 2006
Review panel
Immunology
Regulation
21 CFR 866.5900

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.